Literature DB >> 3493221

Serum antibody and cellular responses in LEW and F344 rats after immunization with Mycoplasma pulmonis antigens.

J W Simecka, G H Cassell.   

Abstract

Mycoplasma pulmonis causes a chronic respiratory disease in rats which is more severe in LEW than in F344 rats. This study compared the ability of each of these rat strains to produce specific immune responses to M. pulmonis antigens. By an enzyme-linked immunosorbent assay, LEW rats were found to produce approximately 10 times lower levels of specific immunoglobulin G (IgG) after immunization with M. pulmonis antigens than F344 rats, while no significant difference was found in the levels of IgM. The difference in IgG levels was due to much greater levels of specific IgG2b (about 50 times) in F344 rats; no differences were found in other subclasses. Nonimmune LEW rats were found to have as much total IgG2b in their sera as unimmunized F344 rats by a single radial immunodiffusion test; thus, the difference was not due to the inability of LEW rats to produce IgG2b. In contrast to the antibody response to M. pulmonis antigens, anti-keyhole limpet hemocyanin IgG responses in LEW and F344 rats were similar, but F344 rats produced significantly more (about 21 times) IgG2b than was found in M. pulmonis responses. Antisera from F344 rats recognized several additional M. pulmonis antigens than antisera from LEW rats; however, this could not explain the differences in the level of IgG2b in LEW and F344 rats. In vitro stimulation of splenic lymphocytes with M. pulmonis antigens from immunized F344 rats produced much greater proliferative responses than in LEW and nonimmune F344 cells. Thus, the susceptible rat strain LEW produced lower cellular and humoral immune responses to M. pulmonis antigens than the resistant rat strain F344 after immunization.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3493221      PMCID: PMC260402          DOI: 10.1128/iai.55.3.731-735.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Genetic control of immune responses to Moloney leukemia virus in rats.

Authors:  J M Jones; F Jensen; J D Feldman
Journal:  J Natl Cancer Inst       Date:  1978-06       Impact factor: 13.506

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Immunofluorescent procedures for mycoplasma identification.

Authors:  R A Del Guidice; M F Barile
Journal:  Dev Biol Stand       Date:  1974

5.  Local and systemic cellular immune responses in guinea-pigs given antigen parenterally or directly into the lower respiratory tract.

Authors:  D R Nash; B Holle
Journal:  Clin Exp Immunol       Date:  1973-04       Impact factor: 4.330

6.  Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.

Authors:  E Engvall; P Perlmann
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

7.  Tissue cultures and mycoplasmas.

Authors:  L Hayflick
Journal:  Tex Rep Biol Med       Date:  1965-06

8.  Murine chronic respiratory disease. Significance as a research complication and experimental production with Mycoplasma pulmonis.

Authors:  J R Lindsey; H J Baker; R G Overcash; G H Cassell; C E Hunt
Journal:  Am J Pathol       Date:  1971-09       Impact factor: 4.307

9.  Strain differences in susceptibility to murine respiratory mycoplasmosis in C57BL/6 and C3H/HeN mice.

Authors:  J K Davis; R F Parker; H White; D Dziedzic; G Taylor; M K Davidson; N R Cox; G H Cassell
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

10.  Protective effect of vaccination against Mycoplasma pulmonis respiratory disease in rats.

Authors:  G H Cassell; J K Davis
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

View more
  13 in total

1.  Interferon gamma and interleukin 4 have contrasting effects on immunopathology and the development of protective adaptive immunity against mycoplasma respiratory disease.

Authors:  Sheetal Bodhankar; Xiangle Sun; Matthew D Woolard; Jerry W Simecka
Journal:  J Infect Dis       Date:  2010-07-01       Impact factor: 5.226

2.  Immunoglobulin class- and subclass-specific responses to Mycoplasma pulmonis in sera and secretions of naturally infected Sprague-Dawley female rats.

Authors:  M B Brown; L Reyes
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

3.  THE MULTIFACETED ROLE OF T CELL-MEDIATED IMMUNITY IN PATHOGENESIS AND RESISTANCE TO MYCOPLASMA RESPIRATORY DISEASE.

Authors:  Nicole A Dobbs; Adam N Odeh; Xiangle Sun; Jerry W Simecka
Journal:  Curr Trends Immunol       Date:  2009

4.  Gender is a major factor in determining the severity of mycoplasma respiratory disease in mice.

Authors:  A L Yancey; H L Watson; S C Cartner; J W Simecka
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Serum antibody does not account for differences in the severity of chronic respiratory disease caused by Mycoplasma pulmonis in LEW and F344 rats.

Authors:  J W Simecka; J K Davis; G H Cassell
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

6.  A novel IL-17-dependent mechanism of cross protection: respiratory infection with mycoplasma protects against a secondary listeria infection.

Authors:  Amy N Sieve; Karen D Meeks; Sheetal Bodhankar; Suheung Lee; Jay K Kolls; Jerry W Simecka; Rance E Berg
Journal:  Eur J Immunol       Date:  2009-02       Impact factor: 5.532

7.  NK cells interfere with the generation of resistance against mycoplasma respiratory infection following nasal-pulmonary immunization.

Authors:  Sheetal Bodhankar; Mathew D Woolard; Xiangle Sun; Jerry W Simecka
Journal:  J Immunol       Date:  2009-07-22       Impact factor: 5.422

8.  Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response.

Authors:  S C Cartner; J W Simecka; J R Lindsey; G H Cassell; J K Davis
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

9.  Specific and nonspecific antibody responses in different segments of the respiratory tract in rats infected with Mycoplasma pulmonis.

Authors:  J W Simecka; P Patel; J K Davis; S E Ross; P Otwell; G H Cassell
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

10.  Impact of experimental genital mycoplasmosis on pregnancy outcome in Sprague-Dawley rats.

Authors:  D A Steiner; M B Brown
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.